Fidelity Investments’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.02M | Sell |
287,316
-2,378,933
| -89% | -$53.6M | ﹤0.01% | 2237 |
|
|
2025
Q4 | $61.3M | Sell |
2,666,249
-4,617,047
| -63% | -$152M | ﹤0.01% | 1358 |
|
|
2025
Q3 | $219M | Buy |
7,283,296
+4,678,708
| +180% | +$140M | 0.01% | 800 |
|
|
2025
Q2 | $94.7M | Buy |
2,604,588
+2,223,166
| +583% | +$80.1M | 0.01% | 1141 |
|
|
2025
Q1 | $13.8M | Sell |
381,422
-14,562
| -4% | -$606K | ﹤0.01% | 1801 |
|
|
2024
Q4 | $16.7M | Sell |
395,984
-241,837
| -38% | -$12M | ﹤0.01% | 1788 |
|
|
2024
Q3 | $35.4M | Sell |
637,821
-9,797
| -2% | -$499K | ﹤0.01% | 1511 |
|
|
2024
Q2 | $26.6M | Sell |
647,618
-134,414
| -17% | -$5.74M | ﹤0.01% | 1548 |
|
|
2024
Q1 | $36.5M | Sell |
782,032
-210,919
| -21% | -$9.95M | ﹤0.01% | 1439 |
|
|
2023
Q4 | $47.5M | Sell |
992,951
-34,834
| -3% | -$1.35M | ﹤0.01% | 1312 |
|
|
2023
Q3 | $36.6M | Buy |
1,027,785
+195,108
| +23% | +$7.73M | ﹤0.01% | 1361 |
|
|
2023
Q2 | $38.4M | Sell |
832,677
-171,347
| -17% | -$7.95M | ﹤0.01% | 1375 |
|
|
2023
Q1 | $40.3M | Sell |
1,004,024
-75,050
| -7% | -$3.22M | ﹤0.01% | 1338 |
|
|
2022
Q4 | $50M | Buy |
1,079,074
+99,295
| +10% | +$3.91M | 0.01% | 1253 |
|
|
2022
Q3 | $40.6M | Sell |
979,779
-178,463
| -15% | -$9.17M | ﹤0.01% | 1329 |
|
|
2022
Q2 | $69.1M | Sell |
1,158,242
-97,282
| -8% | -$5.99M | 0.01% | 1119 |
|
|
2022
Q1 | $91.2M | Sell |
1,255,524
-35,855
| -3% | -$2.49M | 0.01% | 1105 |
|
|
2021
Q4 | $109M | Buy |
1,291,379
+130,394
| +11% | +$10.6M | 0.01% | 1067 |
|
|
2021
Q3 | $105M | Buy |
1,160,985
+286,371
| +33% | +$25.9M | 0.01% | 1086 |
|
|
2021
Q2 | $83.4M | Sell |
874,614
-2,900
| -0.3% | -$302K | 0.01% | 1200 |
|
|
2021
Q1 | $99.9M | Sell |
877,514
-193,985
| -18% | -$26.4M | 0.01% | 1066 |
|
|
2020
Q4 | $148M | Sell |
1,071,499
-98,600
| -8% | -$11.7M | 0.01% | 868 |
|
|
2020
Q3 | $96.2M | Sell |
1,170,099
-272,003
| -19% | -$22.5M | 0.01% | 923 |
|
|
2020
Q2 | $113M | Sell |
1,442,102
-333,608
| -19% | -$22.1M | 0.01% | 828 |
|
|
2020
Q1 | $78.9M | Sell |
1,775,710
-47,664
| -3% | -$2.47M | 0.01% | 847 |
|
|
2019
Q4 | $77.9M | Sell |
1,823,374
-260,247
| -12% | -$10.7M | 0.01% | 1018 |
|
|
2019
Q3 | $89.1M | Sell |
2,083,621
-207,667
| -9% | -$11.3M | 0.01% | 934 |
|
|
2019
Q2 | $145M | Sell |
2,291,288
-226,458
| -9% | -$14.4M | 0.02% | 769 |
|
|
2019
Q1 | $175M | Sell |
2,517,746
-429,178
| -15% | -$24.5M | 0.02% | 698 |
|
|
2018
Q4 | $128M | Sell |
2,946,924
-380,457
| -11% | -$20.8M | 0.02% | 742 |
|
|
2018
Q3 | $254M | Sell |
3,327,381
-131,704
| -4% | -$10.7M | 0.03% | 583 |
|
|
2018
Q2 | $266M | Sell |
3,459,085
-485,897
| -12% | -$31.4M | 0.03% | 553 |
|
|
2018
Q1 | $201M | Buy |
3,944,982
+303,061
| +8% | +$15.3M | 0.02% | 681 |
|
|
2017
Q4 | $169M | Sell |
3,641,921
-15,287
| -0.4% | -$750K | 0.02% | 761 |
|
|
2017
Q3 | $195M | Sell |
3,657,208
-147,017
| -4% | -$8.71M | 0.02% | 694 |
|
|
2017
Q2 | $236M | Sell |
3,804,225
-2,306,402
| -38% | -$139M | 0.03% | 615 |
|
|
2017
Q1 | $414M | Buy |
6,110,627
+227,802
| +4% | +$17.4M | 0.05% | 389 |
|
|
2016
Q4 | $414M | Sell |
5,882,825
-30,250
| -0.5% | -$2.15M | 0.06% | 370 |
|
|
2016
Q3 | $419M | Buy |
5,913,075
+65,292
| +1% | +$4.17M | 0.06% | 373 |
|
|
2016
Q2 | $286M | Buy |
5,847,783
+6,152
| +0.1% | +$398K | 0.04% | 519 |
|
|
2016
Q1 | $370M | Buy |
5,841,631
+18,689
| +0.3% | +$1.22M | 0.05% | 389 |
|
|
2015
Q4 | $653M | Buy |
5,822,942
+22,946
| +0.4% | +$2.29M | 0.09% | 232 |
|
|
2015
Q3 | $559M | Buy |
5,799,996
+419,169
| +8% | +$48M | 0.08% | 268 |
|
|
2015
Q2 | $551M | Buy |
5,380,827
+48,044
| +0.9% | +$3.73M | 0.07% | 309 |
|
|
2015
Q1 | $331M | Buy |
5,332,783
+551,363
| +12% | +$30.6M | 0.04% | 474 |
|
|
2014
Q4 | $210M | Buy |
4,781,420
+187,180
| +4% | +$8.58M | 0.03% | 653 |
|
|
2014
Q3 | $260M | Buy |
4,594,240
+85,347
| +2% | +$4.29M | 0.04% | 533 |
|
|
2014
Q2 | $125M | Buy |
4,508,893
+908,405
| +25% | +$37.4M | 0.02% | 881 |
|
|
2014
Q1 | $85.1M | Buy |
+3,600,488
| New | +$185M | 0.01% | 1068 |
|
Other funds holding RARE
VPM
VCM
RI
SI
BG
Fidelity Investments's RARE Position: Q1 2026 in Review
Fidelity Investments reduced its Ultragenyx Pharmaceutical (RARE) stake by 89% in Q1 2026, selling an estimated $53.6M and leaving 287,316 shares worth $6.02M. The position accounts for ﹤0.01% of the portfolio, ranked #2237.
Fidelity Investments first reported a position in RARE in Q1 2014 and has held it in 49 quarters since. The position peaked at $653M in Q4 2015. 295 funds tracked by Wall St. Rank hold RARE as of Q1 2026.
- Fidelity Investments held 287,316 shares of Ultragenyx Pharmaceutical worth $6.02M as of Q1 2026.
- Fidelity Investments sold 2,378,933 Ultragenyx Pharmaceutical shares in Q1 2026, an estimated $53.6M.
- Ultragenyx Pharmaceutical made up ﹤0.01% of Fidelity Investments's portfolio in Q1 2026, its #2237 holding.
- Fidelity Investments first reported a position in Ultragenyx Pharmaceutical in Q1 2014 and has held it in 49 quarters since.
- Fidelity Investments's Ultragenyx Pharmaceutical position peaked at $653M in Q4 2015.
- 295 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q1 2026.
Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.